These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 6174931)
21. Preangioplasty fibrinolytic therapy using SP-54 including acute and subacute occlusions. Haapanen A; Leinonen A; Seppänen S Ann Radiol (Paris); 1984; 27(4):340. PubMed ID: 6204575 [No Abstract] [Full Text] [Related]
22. [Pentosan polysulfate, adjuvant treatment in transluminal angioplasty of arteries of the legs]. Menanteau B; Gausserand F; Marcus C; Ladam V; Monnier Y Presse Med; 1986 Feb; 15(5):213. PubMed ID: 2421282 [No Abstract] [Full Text] [Related]
23. [Therapy of senile hearing impairment with SP 54 in double-blind experiment]. Mŭller E Med Welt; 1975 Mar; 26(12):574-5. PubMed ID: 1134298 [No Abstract] [Full Text] [Related]
24. Altering the course of proliferative nephritides: the challenge of the 1990s. Wardle EN J Int Med Res; 1992 Sep; 20(5):361-70. PubMed ID: 1280605 [TBL] [Abstract][Full Text] [Related]
26. [Long-term hypolipemic therapy in arteriosclerosis obliterans]. Lasso M; García Merlo S; Alvarez C Rev Clin Esp; 1976 Feb; 140(4):371-6. PubMed ID: 1265322 [No Abstract] [Full Text] [Related]
27. [Effect of heparin, heparin derivatives and heparinoids on blood sugar levels of diabetes mellitus patients]. Bozadzhieva EK; Markovski SG Probl Endokrinol (Mosk); 1978; 24(6):23-30. PubMed ID: 82965 [TBL] [Abstract][Full Text] [Related]
28. Enhanced binding of modified pentosan polysulfate and heparin to bladder--a strategy for improved treatment of interstitial cystitis. Muthusamy A; Erickson DR; Sheykhnazari M; Bhavanandan VP Urology; 2006 Jan; 67(1):209-13. PubMed ID: 16413377 [TBL] [Abstract][Full Text] [Related]
29. [Treatment of acute rheumatic diseases with Probaphen in private medicine]. Müller G ZFA (Stuttgart); 1976 Oct; 52(28):1443-6. PubMed ID: 790808 [No Abstract] [Full Text] [Related]
30. [Prevention trial of thrombosis with pentosane polysulfate in intracardiac dynamic explorations]. Terrier E; Forman J; François A; Paillard J; Baillet J Presse Med; 1985 Jan; 14(1):43. PubMed ID: 2578660 [No Abstract] [Full Text] [Related]
31. [Heparin in the treatment of nephrotic syndrome]. Paunesco-Podeanu A; Buligesco L; Beroniade V Therapeutique; 1970 May; 46(5):571-5. PubMed ID: 5430232 [No Abstract] [Full Text] [Related]
32. Intravesical treatment of interstitial cystitis with a heparin analogue. Bade JJ; Mensink HJ; Laseur M Br J Urol; 1995 Feb; 75(2):260. PubMed ID: 7531593 [No Abstract] [Full Text] [Related]
33. Nephrotic syndrome: a kinetic evaluation of hemostasis and anticoagulant therapy in children. Futrakul P; Poshyachinda V; Poshyachinda M; Sitprija V; Mitrakul C; Kankeerati V J Med Assoc Thai; 1978 Jun; 61(6):309-18. PubMed ID: 670847 [No Abstract] [Full Text] [Related]
34. Effects of various doses of SP 54 on fibrinolytic activity in patients with thrombotic diseases. Losonczy H; Nagy I; Dávid M Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):388-93. PubMed ID: 2465236 [TBL] [Abstract][Full Text] [Related]
35. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection. Fischer AM; Merton RE; Marsh NA; Williams S; Gaffney PJ; Barrowcliffe TW; Thomas DP Thromb Haemost; 1982 Apr; 47(2):109-13. PubMed ID: 6179183 [TBL] [Abstract][Full Text] [Related]
36. [Use of heparin in treating the nephrotic syndrome]. Vat'ian AA Vrach Delo; 1973 May; 5():78-81. PubMed ID: 4757744 [No Abstract] [Full Text] [Related]